Medable vs DeepSeek

Side-by-side comparison of AI visibility scores, market position, and capabilities

DeepSeek leads in AI visibility (93 vs 35)
Medable logo

Medable

EmergingEnterprise AI

Clinical Trials

Medable raised $304M to build the leading decentralized clinical trial (DCT) platform, enabling remote patient participation, eConsent, and wearable data integration for pharmaceutical trials.

AI VisibilityBeta
Overall Score
D35
Category Rank
#235 of 296
AI Consensus
92%
Trend
stable
Per Platform
ChatGPT
33
Perplexity
30
Gemini
30

About

Medable provides the technology infrastructure for decentralized clinical trials (DCTs) — enabling pharmaceutical companies to conduct trials where patients participate from home rather than traveling to research sites. The platform covers the full DCT workflow: electronic informed consent (eConsent), remote patient monitoring via wearables, telemedicine visits, electronic clinical outcome assessments (eCOA), and direct-to-patient drug delivery coordination.

Full profile
DeepSeek logo

DeepSeek

LeaderAI & Machine Learning

LLM Platform

DeepSeek-V3 and R1 models shocked the AI industry with top-tier performance at <1% of OpenAI training costs. 96.88M MAU; open-weights model downloaded 5M+ times. Owned by High-Flyer (Chinese quant fund); demonstrated efficient AI without massive GPU clusters.

AI VisibilityBeta
Overall Score
A93
Category Rank
#11 of 296
AI Consensus
75%
Trend
stable
Per Platform
ChatGPT
96
Perplexity
98
Gemini
92

About

DeepSeek is a Chinese AI research company and LLM platform founded in 2023 as a subsidiary of High-Flyer, a quantitative hedge fund. The company made global headlines in early 2025 when it released DeepSeek-V3 and DeepSeek-R1, large language models that achieved top-tier performance on reasoning and coding benchmarks at a fraction of the training cost of comparable Western models. DeepSeek's engineering innovations—including mixture-of-experts architectures, multi-head latent attention, and efficient RLHF pipelines—demonstrated that frontier AI capability could be achieved with far less compute than previously assumed.\n\nDeepSeek offers its models through an API platform competitive with OpenAI and Anthropic, as well as releasing open-weights versions that can be downloaded and self-hosted. Its R1 reasoning model became especially popular for STEM tasks, coding, and mathematical problem solving. The open-weights strategy has made DeepSeek models a foundational choice for researchers, enterprises running private deployments, and developers seeking cost-efficient inference. DeepSeek's pricing is dramatically below Western API competitors, accelerating adoption globally.\n\nDeepSeek-R1's open-weights release was downloaded over 100 million times and triggered significant recalibration across the AI industry about training efficiency and the cost of frontier capabilities. The platform now serves 96.88 million monthly active users, rivaling major Western AI products in scale. DeepSeek's emergence reshaped the competitive landscape in 2025-2026, forcing cost reductions from OpenAI, Google, and Anthropic, and raising important questions about AI export controls and the global race for AI supremacy.

Full profile

AI Visibility Head-to-Head

35
Overall Score
93
#235
Category Rank
#11
92
AI Consensus
75
stable
Trend
stable
33
ChatGPT
96
30
Perplexity
98
30
Gemini
92
30
Claude
97
30
Grok
88

Key Details

Category
Clinical Trials
LLM Platform
Tier
Emerging
Leader
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Medable
Clinical Trials
Only DeepSeek
LLM Platform

Integrations

Only DeepSeek

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.